Compare ATYR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | NREF |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 258.6M |
| IPO Year | 2015 | 2020 |
| Metric | ATYR | NREF |
|---|---|---|
| Price | $0.78 | $15.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $8.75 | ★ $14.75 |
| AVG Volume (30 Days) | ★ 2.6M | 57.4K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 13.35% |
| EPS Growth | N/A | ★ 132.43 |
| EPS | N/A | ★ 3.08 |
| Revenue | $190,000.00 | ★ $151,560,000.00 |
| Revenue This Year | N/A | $23.96 |
| Revenue Next Year | $18,728.88 | N/A |
| P/E Ratio | ★ N/A | $4.87 |
| Revenue Growth | N/A | ★ 107.15 |
| 52 Week Low | $0.64 | $12.14 |
| 52 Week High | $7.29 | $17.55 |
| Indicator | ATYR | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 67.02 |
| Support Level | $0.70 | $15.03 |
| Resistance Level | $0.83 | $15.30 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 57.87 | 80.15 |
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.